...
首页> 外文期刊>Physiotherapy theory and practice >Comparison of functional and maximal exercise capacity, respiratory and peripheral muscle strength, dyspnea, and fatigue in patients with heart failure with pacemakers and healthy controls: a cross-sectional study
【24h】

Comparison of functional and maximal exercise capacity, respiratory and peripheral muscle strength, dyspnea, and fatigue in patients with heart failure with pacemakers and healthy controls: a cross-sectional study

机译:心力衰竭和健康对照患者功能性和最大运动能力,呼吸和外周肌力量,呼吸和外周肌力量,呼吸困难和疲劳的比较:横断面研究

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Despite major breakthroughs that have recently been made in pacemakers implanted in patients with heart failure (HF), it is clear that functional impairments and symptoms often remain. However, only limited studies have investigated exercise capacity, muscle strength, pulmonary function, dyspnea, and fatigue in these patients. Therefore, we aimed to compare aforementioned outcomes in patients and healthy controls. Methods: A cross-sectional study. Fifty patients with HF with pacemakers (58.90 +/- 10.69 years, NYHA II-III, LVEF: 30.79 +/- 8.78%) and 40 controls (56.33 +/- 5.82 years) were compared. Functional (6-Minute Walking test (6-MWT)) and maximal exercise capacity (Incremental Shuttle Walk test (ISWT)), respiratory (Mouth pressure device) and peripheral muscle strength (Dynamometer), pulmonary function (Spirometry), dyspnea (Modified Medical Research Council Dyspnea scale), and fatigue (Fatigue Severity scale) were evaluated. ClinicalTrial number: NCT03701854. Results: 6-MWT (412.62 +/- 96.51 m versus 610.16 +/- 59.48 m) and ISWT (279.97 m versus 655 m) distances (p < 0.001), pulmonary function (p<0.001), respiratory and peripheral muscle strength (p < 0.001) were significantly lower; dyspnea (p < 0.001) and fatigue (p = .030) scores were higher in patients compared with controls. Conclusion: Maximal and functional exercise capacity is impaired in the majority of patients with HF with pacemakers, respiratory and peripheral muscles are weakened, dyspnea and fatigue perceptions are increased. Patients with pacemakers have to be included in cardiac rehabilitation programs to improve impairments.
机译:背景:尽管最近在植入心力衰竭(HF)患者的起搏器方面取得了重大突破,但很明显,功能损害和症状通常仍然存在。然而,只有有限的研究调查了这些患者的运动能力、肌力、肺功能、呼吸困难和疲劳。因此,我们旨在比较患者和健康对照组的上述结果。方法:横断面研究。对50例使用起搏器的心衰患者(58.90+/-10.69岁,NYHA II-III,LVEF:30.79+/-8.78%)和40例对照组(56.33+/-5.82岁)进行比较。评估功能(6分钟步行试验(6-MWT))和最大运动能力(增量穿梭步行试验(ISWT))、呼吸(口腔压力装置)和外周肌力(测功机)、肺功能(肺活量测定)、呼吸困难(改良医学研究委员会呼吸困难量表)和疲劳(疲劳严重程度量表)。临床试验编号:NCT03701854。结果:6-MWT(412.62+/-96.51米对610.16+/-59.48米)和ISWT(279.97米对655米)距离(p<0.001)、肺功能(p<0.001)、呼吸和外周肌力(p<0.001)显著降低;与对照组相比,患者的呼吸困难(p<0.001)和疲劳(p=0.030)评分更高。结论:大多数有起搏器的心衰患者的最大运动能力和功能性运动能力受损,呼吸和周围肌肉减弱,呼吸困难和疲劳感觉增加。有起搏器的患者必须纳入心脏康复计划,以改善损伤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号